SC 13G Filing

Company

Spyre Therapeutics, Inc.

Filed

June 30, 2023

Accession Number

0001172661-23-002388

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →